Eisai and Teikoku Seal Deal on Aricept Transdermal Patch

摘要

Eisai Co.has announced the conclusion of an agreement with Teikoku Sei-yaku on their joint development of a transdermal-patch formulation of Aricept,its drug to treat Alzheimer's disease,and terminated a similar deal with Nitto Denko.Differences in our strategic positions concerning the joint development have led to our terminating the agreement," a top Eisai official said.It is unknown to what extent the Tokyo-based drug maker had carried its joint developmental efforts with Osaka-based Nitto Denko.